An in vivo model of Met-driven lymphoma as a tool to explore the therapeutic potential of Met inhibitors.
Accornero P, Lattanzio G, Mangano T, Chiarle R, Taulli R, Bersani F, Forni PE, Miretti S, Scuoppo C, Dastrù W, Christensen JG, Crepaldi T, Ponzetto C.
Accornero P, et al. Among authors: miretti s.
Clin Cancer Res. 2008 Apr 1;14(7):2220-6. doi: 10.1158/1078-0432.CCR-07-2064.
Clin Cancer Res. 2008.
PMID: 18381964